background pepsi sever conduit characters body system inflammatory response infect specify sepsisrel biomass use clinic diagnosis therapeutic monitor ration use antibiotic prognosis risk static etc result studi investing express level decoy receptor dcr meghan high patient septic cell model expert perform treat human until vein endothelial cell have jurist lipopolysaccharid lp lipoteicho acid lta zymosan respect sp sb ammonium pyrrolidinedithiocarbam ptc inhibit jk map nfÎºb signal pathway show level higher group control mra protein increase follow treatment also treat inhibitor decrease compare control howe effect concur india secret proceed pathway 